| Market Cap | ₹901Cr |
| ROE | 14.52% |
| P/E Ratio(TTM) | 19.54 |
| EPS(TTM) | 4.60 |
| P/B Ratio | 2.76 |
| Dividend Yield | 0.83% |
| Industry P/E | 40.62 |
| Book Value | 32.53 |
| Debt to Equity | 0.03 |
| Face Value | 5 |
| Parent Organisation | Anuh Pharma |
| Managing Director | Mr. Ritesh Bipin Shah |
| NSE Symbol | ANUHPHR |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 77.66 | ||
| Neuland Laboratories | NA (0.00%) | 120.30 | ||
| Jubilant Pharmova | NA (0.00%) | 36.86 | ||
| Acutaas Chemicals | NA (0.00%) | 62.52 |